Skip to main content
. 2022 Jun 27;204:105370. doi: 10.1016/j.antiviral.2022.105370

Fig. S3.

Fig. S3

Neutralization of SARS-CoV-2 variants in convalescent serum samples collected in 2020. (A) Infectious virus 50% neutralization titers (NT50) of convalescent sera were determined against the indicated infectious SARS-CoV-2 variant isolates. (B) Lentivirus-based pseudovirus 50% neutralization titers (pVNT50) of convalescent sera were determined against the indicated SARS-CoV-2 variants. Horizontal dotted lines represent assay limits of detection.